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AntioxidantBuddleja salviifolia leaves are used for the treatment of eye infections and neurodegenerative conditions in South
Africa. Three phenolic compounds identiﬁed as 4′-hydroxyphenyl ethyl vanillate (1), acteoside (2) and quercetin
(3) from leaf extracts of the B. salviifoliawere investigated for cyclooxygenase-2 (COX-2) inhibition and antiox-
idant activities using β-carotene–linoleic acid and DPPH assays. In silico parameters were also determined for
COX-2. All the compounds exhibited good inhibition activity against COX-2 and moderate antioxidant activities
at a screening concentration of 25.0 μg/ml. Acteoside was the most potent in all assays. It exhibited the lowest
IC50 value (4.28 μg/ml) in the COX-2 and EC50 values of 24.15 and 63.30 μg/ml in the β-carotene–linoleic acid
and DPPH assays respectively. Computational molecular docking showed its molecular interaction with impor-
tant amino acid residues in the catalytic site of COX-2, revealing its potential binding mode at the molecular
level. In silico study revealed that quercetin and acteoside showed the highest binding afﬁnity (dock score of
92.18 and 68.93 k.cal/mol) and good hydrogen bond interactions with active site residues. The activities demon-
strated by these compounds (1–3) suggest that they could be useful inmanagement of inﬂammatory conditions.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Inﬂammation is the response of an organism to invasion by a foreign
body such as bacteria, parasites and viruses. Studies on inﬂammation
have become one major focus of global scientiﬁc research. Adverse ef-
fects of non-steroidal anti-inﬂammatory drugs (NSAIDs) and the long-
term administration of NSAID may induce gastro-intestinal ulcers,
bleeding and renal disorders due to their non-selective inhibition of
both constitutive cyclooxygenases-1 (COX-1) and inducible (COX-2)
isoforms of the enzymes (Robert, 1976; Peskar, 1977; Tapiero et al.,
2002; Dharmasiri et al., 2003; Vittalrao et al., 2011). A selective inhibi-
tion of COX-2 over COX-1 could reduce adverse side effects, such as gas-
tric lesions, observed in the therapeutic use of some NSAID derivatives
(Masferrer et al., 1996; Sahpaz et al., 2002). Reactive oxygen species
(ROS), such as superoxide anion, hydroxyl radicals, and hydrogen per-
oxide are generated in living organisms through numerous metabolic
pathways. The oxidative damage caused by ROS may increase progres-
sion of various diseases in the human body. These include aging, arthri-
tis, cancer, inﬂammation, and heart diseases (Meerson et al., 1982;
Busciglio and Yankner, 1995; Abe and Berk, 1998).
Medicinal plants (MPs) are widely explored in traditional medicines
and drug discovery (Borris, 1996; Clark, 1996; Heinrich, 2000; Yuan and
Lin, 2000). Approximately one-third of the top-selling drugs currentlyhts reserved.on the market were derived from plants (Strohl, 2000). Because of
their broad diversity and wide range of known pharmacological activi-
ties, MPs have served and are still used as a valuable source for new
drug discovery. As part of new drug discovery efforts, a large number
of ingredients have been extracted fromMPs and other natural sources,
and they have been studied for their potential therapeutic effects (Zhu
et al., 1996; Chen et al., 2003). Novel therapeutic mechanisms discov-
ered from studies of MP ingredients have routinely been used to derive
new therapeutic intervention approaches (Evans, 1991). Hence much
more research remains to be done in order to probe the mechanisms
of MP active ingredients. Systematic study of the mechanisms of a
large number of MP ingredients by means of traditional assay based
methods is a costly and time-consuming process due to difﬁculties in
extraction, synthesis, and activity testing of herbal ingredients (Chen
et al., 2003). Therefore alternative approaches for low-cost and rapid
analysis of the mechanisms of MP ingredient action are useful for their
study and exploration (Chen et al., 2003).
The genus Buddleja (Buddlejaceae) consists of about 100 species
distributed in the tropics of America, Asia and Africa. Several Buddleja
species have been widely used in traditional medicine. The leaves of
Buddleja salviifolia (L). Lam. are used for the treatment of eye related ail-
ments and neurodegenerative diseases (Watt and Breyer-Brandwijik,
1962; Hutchings et al., 1996; Van Wyk and Gericke, 2000; Perry et al.,
2003). The aim of this study was to evaluate the anti-inﬂammatory,
antioxidant activities and the in silico parameters of three isolated com-
pounds; 4′-hydroxyphenyl ethyl vanillate (1), acteoside (2) and querce-
tin (3) from B. salviifolia (Pendota et al., 2013).
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Fig. 1. Structures of isolated compounds from B. salviifolia; 4′-hydroxyphenyl ethyl vanillate (1), acteoside (2) and quercetin (3).
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2.1. Plant material collection, extraction, isolation and identiﬁcation of
compounds
Collection, extraction, isolation and identiﬁcation of compounds
1–3 from the ethyl acetate fraction of B. salviifoliawere as previously
described (Pendota et al., 2013). Isolated compounds were identiﬁed
as: 4′-hydroxyphenyl ethyl vanillate, HEV (1), acteoside (2) and
quercetin (3). The structures of compounds 1–3 are illustrated in
Fig. 1.
2.2. Anti-inﬂammatory activity using cyclooxygenase (COX-2) inhibitory
assay
Cyclooxygenase enzyme (COX-2) inhibitory assaywas carried out as
described by Zschocke and Van Staden (2000) to determine the anti-
inﬂammatory potential of the isolated compounds. The controls
consisted of a solvent blank (EtOH), and a background correction inHEV Acteoside
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Fig. 2.Dose-dependent COX-2 percentage inhibition by isolated compounds from Buddleja
salviifolia. Inhibition of prostaglandin synthesis by indomethacin was 70 ± 3.3. 4′-
hydroxyphenyl ethyl vanillate (HEV).which the enzymes were inactivated with 4 N HCl, before adding
[14C] arachidonic acid (16 Ci/mol; 30 μM). Indomethacin (Sigma–
Aldrich, Germany) was used as a reference anti-inﬂammatory drug
(200 μM for COX-2). The compounds were tested at 1 mg/ml and COX
inhibition of the compounds was calculated by comparing the amount
of radioactivity present in the sample to that in the solvent blank
using the equation below:
COX inhibition %ð Þ ¼ 1− DPMextract−DPMbackground
DPMsolventblank−DPMbackground
  
X100
2.3. Antioxidant activity
2.3.1. β-Carotene–linoleic acid model system
The antioxidant potentials of the compounds to inhibit or reduce β-
carotene–linoleic acid oxidation were evaluated using the method of
Amarowicz et al. (2004) with minor modiﬁcations (Moyo et al., 2010).
The negative control was methanol while butylated hydroxytoluene
(BHT) was included as positive control. Values were expressed as per-
centage antioxidant activity (% ANT) using the following equations:
Rate of β−carotene bleaching ¼ ln At¼0
At¼t
 
 1
t
Antioxidant activity %ð Þ ¼ Rcontrol−Rsample
Rcontrol
 
 100Table 1
Cyclooxygenase (COX-2) activity of isolated compounds from Buddleja salviifolia. Values
represent the means ± standard error (n = 4).
Compound IC50 (μg/ml)
1 17.94 ± 0.00
2 4.28 ± 1.13
3 5.08 ± 0.00
4′-Hydroxyphenyl ethyl vanillate (1), acteoside (2), and quercetin (3).
Fig. 3. The plot of Z-score of predicted model COX-2 (-8.54).
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bance at time t = 120 min, and R is the rate of β-carotene bleaching.
The EC50, which is the concentration of the compounds required to pre-
vent or reduce β-carotene bleaching by 50%, was determined for each
compound using GraphPad Prism software.
2.3.2. 1, 1-Diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity
The free radical scavenging activity (RSA) of the compoundswas de-
termined using theDPPH assay as described byKarioti et al. (2004)with
modiﬁcations (Fawole et al., 2010). Compounds were redissolved in
methanol at varying concentrations. The negative control wasmethanol
while ascorbic acid was used as a positive control. Background solutions
with methanol in place of DPPH were included for each compound, in
order to correct any absorbance due to the colour. The testswere carried
out in triplicate. The RSA was calculated using the equation below:
RSA %ð Þ ¼ 1− Acompound−Abackground
Acontrol
  
 100
whereАcompound, Abackground and Acontrolwere the absorbances of
the compound, background solution and negative control, respectively.
The EC50, which is the concentration of the compound required to scav-
enge 50% of DPPH radical, was determined for each extract using
GraphPad Prism software.
2.4. Sequence alignment and homology modelling
The FASTA sequence of COX-2 (P35354) from Homo sapiens
consisting of 18–604 amino acid residues was retrieved from Swiss
Prot database (Westbrook et al., 2002). Comparative modelling usually
starts by searching the Protein Data Bank (PDB) of known protein struc-
tures using the target sequence as the query (Westbrook et al., 2002).
From the BLAST (Basic Local Alignment Search Tool) results, based on
the highest identity and similarity to our target protein, the crystal
structure 1CVU from musmuculus was used as template for homology
modelling (Altschul et al., 1997). Using crystal structural coordinates
of the template, the homology model of COX-2 was modelled on the
base of alignment of target and template. Further, the modelled protein
energy minimization and loop reﬁnement were carried out by applying
CHARMm forceﬁeld and smart minimization algorithm followed by
conjugate gradient algorithmuntil the convergence gradient is satisﬁed.
These procedures were performed by Discovery Studio (Lovell et al.,
2003).
2.4.1. 3D structure validation
The ﬁnal reﬁned model of COX-2 was validated and evaluated by
using Rampage by calculating the Ramachandran plot, protein structure
analysis (ProSA) and root mean square deviation (RMSD). Rampage
server considers dihedral angles ψ against φ of amino acid residues in
protein structure (Manfred, 1995). The ProSA is applied to analyse ener-
gy criteria comparing with Z scores of modelled protein and 3DTable 2
Antioxidant activity of isolated compounds from Buddleja salviifolia by the DPPH and β-
carotene–linoleic acid assays.
Antioxidant activity
Compounds DPPH assay
EC50 (μg/ml)
β-carotene–linoleic acid assay
EC50 (μg/ml)
1 84.03 ± 13.13 55.99 ± 11.92
2 63.30 ± 17.66 24.15 ± 7.11
3 202.06 ± 34.27 77.42 ± 13.93
Ascorbic acid (control) 1.7 ± 0.01 na
BHT (control) na 12.62 ± 2.67
The lower the EC50 value, the better the antioxidant potential of the sample. 4′-
Hydroxyphenyl ethyl vanillate (1), acteoside (2), and quercetin (3). na = not applicable.template structure (Zhang and Skolnick, 2004). RMSD was obtained
by superimposition of 1CVU (template) and modelled COX-2 using
SPDBV.
2.4.2. Ligand generation and optimization
The three dimensional structures of quercetin and acteoside taken
for binding analysis were downloaded in.sdf format from PubChem da-
tabase. New compound (4′-hydroxyphenyl ethyl vanillate) was drawn
using ACD/ChemSketch and saved in mol2 format. Hydrogen bonds
were added by applying the CHARMm forceﬁeld, energy minimization
was carried out with the steepest descent method which follows the
conjugate gradient method till it satisﬁes the convergence gradient.
2.5. Docking studies
The docking method used in this study was LigandFit. To perform
the docking process on the modelled protein, a protocol called
“Dockligands” (LigandFit)was selected among those listed under recep-
tor–ligand interaction protocol cluster. Each ligand compound was
given as input in the parameter meant for “input ligands” and the pro-
tocol was run for each of the inhibitors selected for the study. The vari-
ous conformations for ligand in this docking procedure were generated
by Monte Carlo trials. The ﬁnal energy reﬁnement of the ligand pose
(or) pose optimization was performed with Broyden–Flecher Gold
Farbshanno (BFGS) method. Thus docking analysis of the taken com-
pounds with COX-2 was carried out using Discovery Studio (DS) toFig. 4. The plot of Z-score of 1CVU (template) (-9.01).
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relative stability is also evaluated using binding afﬁnities.
3. Results and discussion
3.1. Cyclooxygenase (COX-2) inhibition assay
The inhibitory effects of the compounds isolated from B. salviifolia
against COX-2 enzymes are presented in Fig. 2. Plant extractswith a per-
centage inhibition above 70%, from 40% to 70%, and below 40% were
considered as showing high,moderate or low inhibitory activity respec-
tively (Tunón et al., 1995). At the highest concentration (25.0 μg/ml), all
the tested compounds exhibited high COX-2 inhibition, (70%, 80% and
90%) for isolated compounds. The IC50 values of compounds 1–3 are
presented in Table 1. The best IC50 value of 4.28 μg/ml was exhibited
by acteoside 2 and the lowest IC50 activity of 17.94 μg/ml was detected
with compound 1 (HEV). Acteoside has strong anti-leukaemic and cyto-
toxic activity against a murine cell line and anti-inﬂammatory activity
(Pettit et al., 1990; Diaz et al., 2004). Compound 1 did not show good
inhibitory activity when compared with the other tested compounds.
3.2. Antioxidant activities
3.2.1. β-Carotene–linoleic acid model system
The β-carotene bleaching assay simulates the oxidation of mem-
brane lipid components and measures antioxidant activity towards
linoleic acid (Ferreira et al., 2006). The mechanism involves the
bleaching of carotenoids such as β-carotene in a heat-induced oxidation
process, and the resultant discolouration being inhibited by antioxi-
dants that donate hydrogen atoms to quench radicals (Huang et al.,Fig. 5. Ramachandran plot of COX-2 p2005). This method is also important to elucidate the antioxidants scav-
enging singlet oxygen. It is well known that singlet oxygen is not a free
radical, but can be formed during radical reactions and also cause fur-
ther reactions. In this assay, compound 2 (24.15 ± 7.11) showed better
lipid peroxidation inhibitory activity compared to other tested com-
pounds (Table 2).
3.2.2. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity
DPPH is widely used to test the ability of compounds to act as free
radical scavengers or hydrogen donors (Blois, 1958). It has also been
used to quantify antioxidants in complex biological systems in recent
years. The EC50 values of scavenging activity on DPPH radical was
found to be 84.03, 63.30 and 202.06 μg/ml for compounds 1, 2 and 3 re-
spectively (Table 2). All compounds showed moderate RSA activity.
Among these, acteoside (2) had the best RSA. Phenolic compounds
such asﬂavonoids, phenolic acids, diterpenes and tannins have received
attention for their high antioxidative activity (Shukla et al., 2009).
3.3. Sequence alignment and homology modelling
The FASTA sequence of COX-2 (P35354) from H. sapiens retrieved
from the Swiss-prot database has 18-604 amino acids (Accession
No: P35354, Entry name: PGH2_HUMAN, Protein name: prostaglandin
G/H synthase). The target sequence was searched for similar sequences
using the Basic Local Alignment Search Tool (BLAST) against PDB. The
BLAST results yielded X-ray structures of 1CVU from musmusculus
with a resolution of 2.40 A° having 87% similarity to target protein.
The sequence alignment was done using sequence analysis protocols
called “Align multiple sequences”. Inputs of protocols were query se-
quence and 1CVU as a template. The theoretical extracellular domainrotein model from Homo sapiens.
Fig. 6. Ramachandram plot of COX-2 model frommusmusculus.
Table 3
Ramachandran plot values showing number of residues in favoured, allowed and outlier region through Rampage evaluation server.
Structure Number of residues in the favoured region (%) Number of residues in the allowed region (%) Number of residues in the outliner region (%)
COX-2 93.3 6.5 0.2
1CVU 95.7 3.6 0.7
Table 4
Summary of docking information of the top ranked poses in each protein.
Docking scores/
Information with COX-2
Quercetin 4′Hydroxyphenyl
ethyl vanillate
Acteoside
Lig score 1 2.2 2.97 5.11
Lig score 2 2.7 4.19 4.37
-PLP 36.35 46.37 85.05
-PLP2 30.97 42.72 92.85
JAIN 0.79 -0.13 3.51
PMF 67.60 65.99 97.02
Dock score 92.18 36.76 63.45
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ogymodels under the proteinmodelling protocol cluster of DS. Fivemo-
lecular models of COX-2 were generated. Out of ﬁve models, Model of
B99990001 has the lowest value in Discrete Optimized Protein Energy
(DOPE). The energy reﬁnement method gives the best conformation
to the model. For optimization and loop reﬁnement, the CHARMm
forceﬁeld and adopted basis NR were applied with 0.001 minimizing
RMS gradient and 2000 minimizing steps.
Geometric evaluations of themodelled 3D structurewere performed
using Rampage. The Ramachandran plot of our model shows that 93.3%
of residues were found in the favoured region, 6.5% in allowed regions
and 0.2% were in the outlier region as compared to 1CVU template
(95.7%, 3.6%, and 0.7%) respectively. The Ramachandran plot for COX-
2 model and the template (1CVU) are shown in Figs. 5 and 6 and the
plot statistics are represented in Table 3. Validation was carried out by
ProSA to obtain the Z-score value for the comparison of compatibility.
The Z-score plot shows values of proteins determined by NMR (repre-
sented in dark blue colour) and by X-ray (represented in light blue col-
our) using ProSA program. The two black dots represent Z-scores of ourmodel (−8.54) and template (−9.01) Figs. 3 and 4. These scores indi-
cate the overall quality of the modelled 3D structure of COX-2. The
ProSA 2003 results and Ramachandran Plot revealed that the optimized
model is satisfactory andwas thus considered reliable for the rest of the
study.
To study the bindingmodes of the isolated compounds as drugmol-
ecules in the active sites of modelled human COX-2, the molecular
Fig. 7. Hydrogen bond interaction with 4′-hydroxyphenyl ethyl vanillate. Fig. 9. Hydrogen bond interaction with quercetin.
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work, COX-2 was docked with 4′-hydroxyphenyl ethyl vanillate (HEV),
acteoside and quercetin; as a result, ten different conformations were
generated for each protein, but only top ranked docked complex score
was considered for binding afﬁnity analysis. The different score values
as showed in Table 4 include Ligscore 1, Ligscore 2, PLP 1, PLP 2, JAIN,
PMF and dock score. The best docked poses based on their interaction
energies with respective protein active site residues were done using
different scoring functions. Two important parameters have been con-
sidered for selecting potential compounds among the given input: (i)
Hydrogen bond details of the top-ranked pose and (ii) prediction of
binding energy between the docked ligands and the protein using vari-
ous scores. The results revealed that HEV was having a dock score of
46.93with two hydrogen bonds GLU 520 and LYS 511 (Fig. 7), acteoside
a dock score of 68.93 with three hydrogen bonds GLN 172, HIS 357 and
VAL 413 (Fig. 8) while quercetine had a dock score of 92.18 k.cal/mol
with two hydrogen bonds GLN 172 and TYR 354 (Fig. 9).
4. Conclusions
A comparative homologymodel of COX-2 has been built, reﬁned and
validated using crystal structure of (1CVU) as a template which shows
the highest overall sequence homology. By using structural and sequen-
tial analysis, we conﬁrmed that the homology modelled 3D structure of
COX-2was reasonable. The development of novel compoundswith bio-
logical activity is urgently needed. In the present study the COX-2 pro-
tein was successfully docked onto both HEV, acteoside and quercetinFig. 8. Hydrogen bond interaction with acteoside.for drug interaction studies to keep track in the ongoing race between
drug development and new drugs especially new compounds which
are more important for the discovery of new hits using molecular
methods. The ﬁtness scores of HEV, acteoside and quercetinwere calcu-
lated using the ligand ﬁt DS software. Fitness score values substantiate
the hypothesis that quercetin has the potential to inhibit the COX-2
protein.
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